Health
UPDATE 2-Regeneron to stop enrolling very sick COVID-19 patients in antibody trial – Reuters
Regeneron Pharmaceuticals said on Friday it would stop enrolling patients receiving advanced COVID-19 care in a trial testing its experimental antibody treatment…
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid
(Reuters) – Regeneron Pharmaceuticals said on Friday it would stop enrolling patients receiving advanced COVID-19 care in a trial testing its experimental antibody treatment in hospitalized patients, based on the recommendation of an independent safety board.
The recommendation was based on a potential safety signal…
-
General24 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News24 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General17 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank